Eltanexor Uses, Dosage, Side Effects and more
Eltanexor is under investigation in clinical trial NCT02649790 (Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/refractory Cancer Indications).
| Attribute | Details |
|---|---|
| Trade Name | Eltanexor |
| Generic | Eltanexor |
| Eltanexor Other Names | Eltanexor |
| Type | |
| Formula | C17H10F6N6O |
| Weight | Average: 428.298 Monoisotopic: 428.082027944 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
